Blogs about Biotechnology, Pharmaceutical and Healthcare
I recently published an article on that garnered a lot of attention. It was titled,”The Myth of the Entitled Single Mother Remains as Relevant as Ever.” In it, I reversed the popularized notion that single mothers are a societal liability and suggested that instead, they are powerful forces in our local economies and influential leaders [...]
From years of writing about chronic pain and illness, I’ve learned that young people carry several extra burdens, especially when their disability is invisible (as is more often the case than not). This piece focuses on young people, although some of its points apply to people of any age, depending on their circumstances. 1. Young [...]
By Ronny Hyman: Flamel Technologies (FLML): Great Buying Opportunity Before Earnings Inflection The biotech sell-off presents a great buying opportunity in Flamel Technologies shares. The stock has declined more than 30% over three recent trading days despite significant improvement in fundamentals that should drive much higher earnings potential this year and next. The shares appreciated nearly...
Every year, it is estimated that more than 126,000 hospitalizations and nearly 17,000 deaths in this country are linked to overuse of over-the-counter (OTC) pain medicine ingredients — specifically acetaminophen and NSAIDs (nonsteroidal anti-inflammatory drugs). In my own practice, it’s not uncommon to find patients who are taking two to four times the recommended doses. [...]
This week's news featured our ambitious new clinical trial aiming to advance treatment for lung cancer, plus goggles for surgery and 3D-printed cancer cells.
You won’t read about the International Classification of Disease (ICD) on TMZ or hear it discussed on The View, but it has the potential to be an unpleasant October surprise in the healthcare world. It is a list of codes that physicians and hospitals use when billing insurance companies. These codes cover all manner of [...]
Postmodern cultural values have seriously impacted medical care and the patient-physician relationship. Corporate control of medical care, computerization of medical information and consumerism in the clinical encounter, plus the destruction of the myth of the physician are all embodiments of postmodern values. Continue reading ... Your patients are rating you online: How to respond. Manage [...]
In a recent note, a guest blogger, Nial Toner, raised the issue of what I will call distracted diagnostics for the purpose of this discussion (see: Cloud Computing in Digital Pathology: Addressing Some Pressing Needs). Here is a paragraph from his no...
In the first comprehensive study of the DNA on dollar bills, New York University researchers identified 3,000 types of bacteria in all—many times more than in previous studies that examined samples under a microscope.
Researchers have developed a microbial fuel cell that can generate small but usable amounts of power from human saliva.
Advisory committee briefing documents state that the fixed-dose combination of immediate-release morphine and oxycodone was not superior to either of its individual components with regard to oxygen desaturation rate.
A proposed immigration law currently under discussion in the UK parliament could be devastating for asylum seekers living with HIV, deterring them from accessing primary care. As national borders become increasingly open, and conflict escalates in many parts of the world, numbers of people seeking asylum in Western countries continue to rise. And asylum seekers [...]
Harvard neuroscientists have made a discovery that turns 160 years […]
A new article published online in The Gerontologist reports that among older […]
Nora Therapeutics Inc. (reproductive medicine) completed an $18mm Series B round led by new investor Novo AS, with returning backers Burrill & Co., Prospect Venture Partners, Rho Ventures, and Vivo Capital also particpating. A Novo partner will join...
GlaxoSmithKline exec Klaus Edvardsen says the new label should give drug a boost, as previous indication was very restrictive. Approved in 2009, Arzerra had just £75 million in 2013 worldwide sales.
Office of Prescription Drug Promotion is evaluating which questions best capture a consumer’s perception of a drug after exposure to an ad.
Scientists at Sanford-Burnham Medical Research Institute (Sanford-Burnham) provide compelling and conclusive evidence that antiestrogen resistance in breast cancer cells requires the interaction between proteins called BCAR1 and BCAR3. In the study, published in the Journal of Biological Chemistry, the researchers also identified a signaling pathway that is crucial for drug resistance mediated by...
Public companies in San Diego’s biotech industry have been on quite the roller coaster, a trend reflected in how that sector is represented in the San Diego Business Journal’s new list of the 50 largest local public companies, ranked by revenue in fiscal 2013.